Loading
The molecular landscape: the targets and how often each appears, the pathways, the mechanics stages and the preclinical models.
The targets of this cancer's medicines and the ones linked to it directly.
| Target / alteration | Prevalence | Measure | Source |
|---|---|---|---|
| EGFR | 80-90% | Overexpression by IHC | Wikipedia |
| PD-L1 KEYNOTE-048 | 80-85% | CPS >=1 | Wikipedia |
| PIK3CA / PI3K-alpha HPV+ enriched | 15-20% | Activating mutation | cBioPortal (TCGA) |
How common each drug target or alteration is in this cancer. Population-level and approximate; see the target page for detail. Full matrix.
5 cell lines, 1 mouse models and 5 repositories are listed for this cancer. See them →